B. Braun wins FDA approval for generic Sugammadex Injection, launches July 28
The single-dose vial marks B. Braun Medical’s first generic pharmaceutical vial launch in the U.S. and adds an AP-rated alternative to BRIDION for acute care anesthesia reversal.